Shatha AbuHammad (@shathaabuhammad) 's Twitter Profile
Shatha AbuHammad

@shathaabuhammad

Scientist @danafarber @harvardmed 🧬🔬🧪

ID: 1117354080

calendar_today24-01-2013 17:54:22

33 Tweet

54 Followers

198 Following

Javier F Caceres (@javierfcaceres1) 's Twitter Profile Photo

A highly exciting issue on RNA condensates, edited by Nobel Laureate, Tom Cech, will be appearing on the January issue of the RNA journal @RNAjournal

A highly exciting issue on RNA condensates, edited by Nobel Laureate, Tom Cech, will be appearing on the January issue of the RNA journal @RNAjournal
Dana-Farber News (@danafarbernews) 's Twitter Profile Photo

For the first time, the U.S. FDA has approved an #immunotherapy drug given after surgery for certain patients with #kidneycancer. The approval of adjuvant pembrolizumab was based on clinical testing led by Dana-Farber's Toni Choueiri, MD (Toni Choueiri, MD): ms.spr.ly/6019k5xyf

Vishal Navani, MD (@navstruck) 's Twitter Profile Photo

🧵Grateful to share our work JAMA Oncology Daniel Heng outlining the rapid pace of change in advanced #kidneycancer #renalcellcarcinoma. A brief tweetorial. Combination approaches, IOIO and IO/VEGF have changed the paradigm for patients...1/4 jamanetwork.com/journals/jamao…

Ingo Hartung (@hartungingo) 's Twitter Profile Photo

More fireworks after 6 pm at #AACR23: #CICR townhall with 3 awesome talks about molecular glue degraders. Michael Rapé (Rapé Lab), Riccardo Sabatini (Orionis Biosciences) & Mary Matyskiela (neomorphinc). Chaired by Ben Ebert (Dana-Farber Chemical Biology Program). Glueing everybody to their seats. AACR #TPD

More fireworks after 6 pm at #AACR23: #CICR townhall with 3 awesome talks about molecular glue degraders. Michael Rapé (<a href="/RapeLab/">Rapé Lab</a>), Riccardo Sabatini (<a href="/OrionisBio/">Orionis Biosciences</a>) &amp; Mary Matyskiela (<a href="/neomorphinc/">neomorphinc</a>). Chaired by Ben Ebert (<a href="/DFCI_ChemBio/">Dana-Farber Chemical Biology Program</a>). Glueing everybody to their seats. <a href="/AACR/">AACR</a> #TPD
Chief Executive Officer VCCC Alliance (@prof_g_mcarthur) 's Twitter Profile Photo

Front line role of our leading cancer researchers at #AACR23 in tackling one of cancers holy grails - targeting the RAS oncogene Ben Solomon #JayeshDesai abstractsonline.com/pp8/#!/10828/s…

Front line role of our leading cancer researchers at #AACR23 in tackling one of cancers holy grails - targeting the RAS oncogene <a href="/bensolomon1/">Ben Solomon</a> #JayeshDesai abstractsonline.com/pp8/#!/10828/s…
cees dekker - now at @ceesdekker.bsky.social (@cees_dekker) 's Twitter Profile Photo

Today, we publish a paper in nature that describes how the DNA-binding protein CTCF regulates DNA loop formation by cohesin. This is a collaboration with Jan-Michael Peters' lab at IMP, greatly led by 1st authors Iain Davidson (Vienna) & Roman Barth (CDlab at Delft) 1/

Today, we publish a paper in <a href="/Nature/">nature</a> that describes how the DNA-binding protein CTCF regulates DNA loop formation by cohesin. 

This is a collaboration with Jan-Michael Peters' lab at <a href="/IMPvienna/">IMP</a>, greatly led by 1st authors Iain Davidson (Vienna) &amp; <a href="/RomanBarth2/">Roman Barth</a> (CDlab at Delft)
1/
Stuart Schreiber (@schreiberstuart) 's Twitter Profile Photo

1/2. Lots of mysteries surrounding glue mechanisms, so its nice to see hydrophobic shielding of hydrogen bonds highlighted here by @Dereklowe. I'll bet there will be other surprises uncovered in the future. science.org/content/blog-p…

Stuart Schreiber (@schreiberstuart) 's Twitter Profile Photo

How can you uncover novel biological mechanisms beginning with observations from human genetics? Read this: Large-scale variant-to-function mapping in primary hematopoietic stem and progenitor cells from Xavier Lab sciencedirect.com/science/articl…

Mark Dawson (@maf_dawson) 's Twitter Profile Photo

The career question I get asked the most is “why did I become a Physician-Scientist” - too often I give a vanilla answer to this - some colleagues have a Eureka moment- for me it was uncertainty, failure & extraordinary mentorship that set me on my journey nature.com/articles/s4301…

IRB Barcelona (@irbbarcelona) 's Twitter Profile Photo

🎯Targeted protein degradation as a therapeutic strategy: the focus of the 39th #BarcelonaBioMed Conference. 🗣The Fundación BBVA & #IRBBarcelona are bringing together in #Barcelona more than 150 scientists from 🌏all over the world to discuss the latest advances in this

🎯Targeted protein degradation as a therapeutic strategy: the focus of the 39th #BarcelonaBioMed Conference.

🗣The <a href="/FundacionBBVA/">Fundación BBVA</a>  &amp; #IRBBarcelona are bringing together in #Barcelona more than 150 scientists from 🌏all over the world to discuss the latest advances in this
Ryan Potts (@pottslab) 's Twitter Profile Photo

🔥🔥 Exciting developments on novel quality control mechanisms by the UBR5 E3 ubiquitin ligases. Potential opportunity for molecular glue discovery to take on some challenging transcription factors. Congrats Rapé Lab Thomä Lab et al.

Stuart Schreiber (@schreiberstuart) 's Twitter Profile Photo

Screening preselected presenter (FKBP12) and target (mTOR) proteins to discover molecular glues exemplified by the discovery of a synthetic mimic of rapamycin chemrxiv.org/engage/chemrxi…

Screening preselected presenter (FKBP12) and target (mTOR) proteins to discover molecular glues exemplified by the discovery of a synthetic mimic of rapamycin chemrxiv.org/engage/chemrxi…
David R. Liu (@davidrliu) 's Twitter Profile Photo

In a major milestone for science, for medicine, and for patients, the world’s first CRISPR drug has been approved in the UK. “A new treatment for sickle-cell disease and transfusion-dependent β-thalassemia has been authorised by the Medicines and Healthcare products Regulatory